November 2019 | AIChE

You are here

November 2019

SAChE® – Risk Based Process Safety - Manage Risk: Training and Procedures

eLearning (online) Course
Chemical processes are prevalent in colleges, universities, research and design as well as industry. These process are instrumental to learning, and...

Elizabeth Lewis

Dr. Lewis joined NutraSteward as Director in 2016.  She has an established track record of providing consultancy services to clients wishing to navigate the regulatory approval processes for novel food and animal feed ingredients.  Over the past 10 years, she has collaborated closely with numerous international clients to develop robust regulatory strategies to market.  She has extensive experience of the preparation, submission and stewardship of successful scientific applications for novel food and feed ingredients in Europe, the U.S. and Canada.  In this role, she...Read more

Michael Kopcha

Michael Kopcha, Ph.D., R.Ph. is the Director of the FDA’s Office of Pharmaceutical Quality (OPQ). This office has over 1,300 staff responsible for assuring the availability of quality medicines for the American public through assessment, inspection, surveillance, research, and policy. OPQ contributes to the assessment of nearly every type of human drug marketing application including New Drug Applications (NDAs), Abbreviated New Drug Applications (ANDAs), and Biologics License Applications (BLAs), including 351(k) applications (i.e., biosimilars). OPQ also performs the quality assessment...Read more

Laura Crowell

Laura Crowell is a Director in Integrated Process Development at Sunflower Therapeutics PBC, a biotech startup focused on dramatically reducing the time and cost to develop and manufacture biologics for patients around the world. In her current role, Laura oversees ongoing efforts to develop right-sized and efficient manufacturing approaches for protein-based therapeutics and vaccines using strain engineering, integrated process development, and automated multi-product facilities.

Laura received her Ph.D. (2020) and M.S. (2015) in Chemical Engineering from MIT and her B.S. (2014) in...Read more

Jon Dieringer

Jon Dieringer, Ph.D. is a Sr. Research Scientist at Eli Lilly and Company in the Small Model Design & Development (SMDD) organization. He has extensive experience in experiment and instrument automation, data analysis and information management. At Lilly, his work focuses on instrument automation and systems integration to expand applications of PAT for continuous processing. To that end, he has driven the automation of HPLC for online process monitoring for continuous drug substance manufacturing, including data acquisition, result verification and communication with process control....Read more

Pages